Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sabbaj, Jacobo"'
Autor:
Gotuzzo, Eduardo, Guerra, Jorge G., Benavente, Luis, Palomino, Juan C., Carrillo, Carlos, Lopera, Julio, Delgado, Freddy, Nalin, David R., Sabbaj, Jacobo
Publikováno v:
The Journal of Infectious Diseases, 1988 Jun 01. 157(6), 1221-1225.
Externí odkaz:
https://www.jstor.org/stable/30135751
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); 1983, Vol. 11 Issue suppl_B, p175-181, 7p
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); 1982, Vol. 9 Issue suppl_A, p121-124, 4p
Publikováno v:
Annals of Internal Medicine; Oct72, Vol. 77 Issue 4, p629, 10p, 1 Diagram, 6 Charts
Publikováno v:
The American Journal of Medicine. 82:75-78
Twenty-five patients with urinary tract infection were treated with norfloxacin, a fluoroquinolone antibacterial with a wide spectrum of activity for an oral agent. Of 22 patients who were evaluable, 20 had complicated urinary tract infection; infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19e6628624c13c10a09dd2f3c6b9f3bc
https://doi.org/10.1016/0002-9343(87)90623-1
https://doi.org/10.1016/0002-9343(87)90623-1
Publikováno v:
Archives of Internal Medicine; February 1970, Vol. 125 Issue: 2 p282-286, 5p
Publikováno v:
Applied Microbiology; December 1971, Vol. 22 Issue: 6 p1008-1011, 4p
Publikováno v:
The American journal of medicine. 82(6B)
A retrospective analysis of data from the treatment of 95 men with nonbacteremic urinary tract infections (UTIs) (clean-catch urinary bacterial count greater than or equal to 10 5 colony-forming units/ml) who received norfloxacin (400 mg orally twice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfeddf0aae768a2f44ae6362ae8365a8
https://pubmed.ncbi.nlm.nih.gov/3300314
https://pubmed.ncbi.nlm.nih.gov/3300314
